Inhibition of T-cell activation attenuates hypertension, TNFα, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance

Am J Reprod Immunol. 2016 Oct;76(4):272-9. doi: 10.1111/aji.12547. Epub 2016 Aug 1.

Abstract

Problem: Angiogenic imbalance during pregnancy is associated with immune activation, hypertension, increased T cell infiltration, and neurological insults.

Method of study: On gestational day (GD) 12, timed-pregnant rats were infused with anti-angiogenic factors sFlt-1 and sEndoglin (4.7 and 7 μg/kg) to create HELLP syndrome via mini-osmotic pumps for 8 days, with a subset of these rats having Orencia (2 mg/kg) infused on GD13. On GD19, blood-brain barrier (BBB) permeability was evaluated via Evan's Blue infusion, blood was collected for T-cell measurements, inflammatory cytokine secretion. Brain tissues were also collected to examine inflammatory cytokine infiltration.

Results: T-cell attenuation with Orencia decreased circulating CD4(+) and CD8(+) T cells, circulating tumor necrosis factor alpha (TNFα) and IL-17, BBB permeability and significantly decreased biochemical evidence of HELLP compared to untreated HELLP rats.

Conclusions: These data support the hypothesis that T cells have a critical role in contributing to the pathophysiology that is seen in angiogenic imbalance during pregnancy.

Keywords: CD4+ T cells; HELLP syndrome; TNFa; blood-brain barrier; hypertension, pregnancy brain.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Abatacept / therapeutic use
  • Angiogenesis Inhibitors / administration & dosage
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Blood-Brain Barrier*
  • Capillary Permeability
  • Disease Models, Animal
  • Endoglin / administration & dosage
  • Female
  • HELLP Syndrome / drug therapy
  • HELLP Syndrome / immunology*
  • Humans
  • Hypertension
  • Inflammation Mediators / metabolism
  • Interleukin-17 / metabolism
  • Lymphocyte Activation
  • Neovascularization, Pathologic*
  • Pregnancy*
  • Rats
  • Rats, Sprague-Dawley
  • T-Lymphocytes / immunology*
  • Tumor Necrosis Factor-alpha / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / administration & dosage
  • Vascular Endothelial Growth Factor Receptor-1 / immunology

Substances

  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents
  • Endoglin
  • Eng protein, mouse
  • Inflammation Mediators
  • Interleukin-17
  • Tumor Necrosis Factor-alpha
  • Abatacept
  • Flt1 protein, mouse
  • Vascular Endothelial Growth Factor Receptor-1